XML 30 R18.htm IDEA: XBRL DOCUMENT v3.21.2
Revenue
9 Months Ended
Sep. 30, 2021
Revenue From Contract With Customer [Abstract]  
Revenue

(12) Revenue

The company recognizes revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. Our estimate for amounts not expected to be collected based on historical experience will continue to be recognized as a reduction to net revenue. However, subsequent changes in estimate of collectability due to a change in the financial status of a payer, for example a bankruptcy, will be recognized as bad debt expense in operating charges.

The performance obligation is separately identifiable from other promises in the customer contract. As the performance obligations are met (i.e.: room, board, ancillary services, level of care), revenue is recognized based upon allocated transaction price. The transaction price is allocated to separate performance obligations based upon the relative standalone selling price. In instances where we determine there are multiple performance obligations across multiple months, the transaction price will be allocated by applying an estimated implicit and explicit rate to gross charges based on the separate performance obligations.

In assessing collectability, we have elected the portfolio approach.  This portfolio approach is being used as we have large volume of similar contracts with similar classes of customers. We reasonably expect that the effect of applying a portfolio approach to a group of contracts would not differ materially from considering each contract separately.  Management’s judgment to group the contracts by portfolio is based on the payment behavior expected in each portfolio category.  As a result, aggregating all of the contracts (which are at the patient level) by the particular payer or group of payers, will result in the recognition of the same amount of revenue as applying the analysis at the individual patient level.

We group our revenues into categories based on payment behaviors.  Each component has its own reimbursement structure which allows us to disaggregate the revenue into categories that share the nature and timing of payments.  The other patient revenue consists primarily of self-pay, government-funded non-Medicaid, and other.

 


 

 

The following table disaggregates our revenue by major source for the three and nine-month periods ended September 30, 2021 and 2020 (in thousands):

 

 

For the three months ended September 30, 2021

 

 

Acute Care

 

 

Behavioral Health

 

 

Other

 

 

Total

 

Medicare

$

310,483

 

 

17

%

 

$

96,219

 

 

7

%

 

 

 

 

 

$

406,702

 

 

13

%

Managed Medicare

 

280,674

 

 

15

%

 

 

66,249

 

 

5

%

 

 

 

 

 

 

346,923

 

 

11

%

Medicaid

 

136,989

 

 

8

%

 

 

146,281

 

 

11

%

 

 

 

 

 

 

283,270

 

 

9

%

Managed Medicaid

 

176,497

 

 

10

%

 

 

326,789

 

 

25

%

 

 

 

 

 

 

503,286

 

 

16

%

Managed Care (HMO and PPOs)

 

674,396

 

 

37

%

 

 

349,275

 

 

26

%

 

 

 

 

 

 

1,023,671

 

 

32

%

UK Revenue

 

0

 

 

0

%

 

 

173,728

 

 

13

%

 

 

 

 

 

 

173,728

 

 

6

%

Other patient revenue and adjustments, net

 

69,935

 

 

4

%

 

 

117,442

 

 

9

%

 

 

 

 

 

 

187,377

 

 

6

%

Other non-patient revenue (a)

 

173,053

 

 

9

%

 

 

52,310

 

 

4

%

 

 

5,679

 

 

 

231,042

 

 

7

%

Total Net Revenue

$

1,822,027

 

 

100

%

 

$

1,328,293

 

 

100

%

 

$

5,679

 

 

 

3,155,999

 

 

100

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

For the nine months ended September 30, 2021

 

 

Acute Care

 

 

Behavioral Health

 

 

Other

 

 

Total

 

Medicare

$

954,207

 

 

18

%

 

$

277,438

 

 

7

%

 

 

 

 

 

$

1,231,645

 

 

13

%

Managed Medicare

 

830,627

 

 

16

%

 

 

185,323

 

 

5

%

 

 

 

 

 

 

1,015,950

 

 

11

%

Medicaid

 

418,335

 

 

8

%

 

 

526,945

 

 

13

%

 

 

 

 

 

 

945,280

 

 

10

%

Managed Medicaid

 

473,256

 

 

9

%

 

 

995,749

 

 

24

%

 

 

 

 

 

 

1,469,005

 

 

16

%

Managed Care (HMO and PPOs)

 

1,862,012

 

 

35

%

 

 

1,070,165

 

 

26

%

 

 

 

 

 

 

2,932,177

 

 

31

%

UK Revenue

 

0

 

 

0

%

 

 

510,614

 

 

13

%

 

 

 

 

 

 

510,614

 

 

5

%

Other patient revenue and adjustments, net

 

248,342

 

 

5

%

 

 

366,669

 

 

9

%

 

 

 

 

 

 

615,011

 

 

7

%

Other non-patient revenue (a)

 

484,221

 

 

9

%

 

 

142,224

 

 

3

%

 

 

20,739

 

 

 

647,184

 

 

7

%

Total Net Revenue

$

5,271,000

 

 

100

%

 

$

4,075,127

 

 

100

%

 

$

20,739

 

 

$

9,366,866

 

 

100

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

For the three months ended September 30, 2020

 

 

Acute Care

 

 

Behavioral Health

 

 

Other

 

 

Total

 

Medicare

$

319,259

 

 

20

%

 

$

120,691

 

 

9

%

 

 

 

 

 

$

439,950

 

 

15

%

Managed Medicare

 

234,169

 

 

15

%

 

 

62,618

 

 

5

%

 

 

 

 

 

 

296,787

 

 

10

%

Medicaid

 

160,671

 

 

10

%

 

 

159,756

 

 

12

%

 

 

 

 

 

 

320,427

 

 

11

%

Managed Medicaid

 

126,979

 

 

8

%

 

 

316,683

 

 

24

%

 

 

 

 

 

 

443,662

 

 

15

%

Managed Care (HMO and PPOs)

 

585,333

 

 

36

%

 

 

321,719

 

 

25

%

 

 

 

 

 

 

907,052

 

 

31

%

UK Revenue

 

0

 

 

0

%

 

 

155,323

 

 

12

%

 

 

 

 

 

 

155,323

 

 

5

%

Other patient revenue and adjustments, net

 

56,188

 

 

3

%

 

 

127,322

 

 

10

%

 

 

 

 

 

 

183,510

 

 

6

%

Other non-patient revenue (b)

 

127,404

 

 

8

%

 

 

35,479

 

 

3

%

 

 

2,947

 

 

 

165,830

 

 

6

%

Total Net Revenue

$

1,610,003

 

 

100

%

 

$

1,299,591

 

 

100

%

 

$

2,947

 

 

$

2,912,541

 

 

100

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

For the nine months ended September 30, 2020

 

 

Acute Care

 

 

Behavioral Health

 

 

Other

 

 

Total

 

Medicare

$

909,594

 

 

20

%

 

$

346,879

 

 

9

%

 

 

 

 

 

$

1,256,473

 

 

15

%

Managed Medicare

 

638,931

 

 

14

%

 

 

181,835

 

 

5

%

 

 

 

 

 

 

820,766

 

 

10

%

Medicaid

 

420,082

 

 

9

%

 

 

488,864

 

 

13

%

 

 

 

 

 

 

908,946

 

 

11

%

Managed Medicaid

 

358,770

 

 

8

%

 

 

900,105

 

 

23

%

 

 

 

 

 

 

1,258,875

 

 

15

%

Managed Care (HMO and PPOs)

 

1,558,765

 

 

34

%

 

 

955,530

 

 

25

%

 

 

 

 

 

 

2,514,295

 

 

30

%

UK Revenue

 

0

 

 

0

%

 

 

428,795

 

 

11

%

 

 

 

 

 

 

428,795

 

 

5

%

Other patient revenue and adjustments, net

 

198,983

 

 

4

%

 

 

371,517

 

 

10

%

 

 

 

 

 

 

570,500

 

 

7

%

Other non-patient revenue (b)

 

513,433

 

 

11

%

 

 

191,298

 

 

5

%

 

 

8,581

 

 

 

713,312

 

 

8

%

Total Net Revenue

$

4,598,558

 

 

100

%

 

$

3,864,823

 

 

100

%

 

$

8,581

 

 

$

8,471,962

 

 

100

%

 

(a) Acute Care includes CARES Act and other grant revenue of $2 million and $13 million recorded in the three and nine-months periods ended September 30, 2021, respectively.  Behavioral Health includes CARES Act and other grant revenue of $114,000 and $2 million recorded in the three and nine-months periods ended September 30, 2021, respectively.  

(b)  Acute Care includes CARES Act and other grant income of $4 million and $161 million recorded in the three and nine-months periods ended September 30, 2020, respectively.  Behavioral Health includes the reversal of CARES Act and other grant income of $9 million and CARES Act and other grant income of $52 million recorded in the three and nine-months periods ended September 30, 2020, respectively

As an accounting policy election, we have utilized ASC 958 by analogy to recognize funds received under the CARES Act from the Provider Relief Fund as revenue, given no direct authoritative guidance available to for-profit organizations to recognize revenue for government contributions and grants.  CARES Act revenues may be subject to future adjustments based on future changes to statutes.